+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biodegradable Sinus Drug Stent System Market - Global Forecast 2026-2032- Product Image
Biodegradable Sinus Drug Stent System Market - Global Forecast 2026-2032- Product Image
Sale

Biodegradable Sinus Drug Stent System Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6080701
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biodegradable Sinus Drug Stent System Market is projected to reach USD 74.36 Million in 2026. It is expected to continue growing at a CAGR of 9.13%, reaching USD 125.54 Million by 2032.

Biodegradable Sinus Drug Stent Systems: Executive Overview

Biodegradable sinus drug stent systems are absorbable devices designed to support sinus drainage and deliver medication locally after endoscopic sinus procedures. Their clinical value is linked to maintaining surgical openings, reducing localized inflammation, and limiting the need for repeated intervention while the material gradually resorbs. Adoption depends on demonstrated safety, consistent drug release, ease of placement, clinician training, reimbursement conditions, and alignment with evidence-based treatment pathways.

Clinical Integration Is Reshaping Sinus Care

The landscape is shifting from procedure-only management toward integrated postoperative care combining surgery, local pharmacotherapy, drug delivery, and follow-up monitoring. Biodegradable designs may reduce the burden associated with device removal, but their use requires careful patient selection, attention to anatomy, infection risk, healing patterns, and compatibility with existing surgical techniques. Evidence generation is increasingly emphasizing comparative clinical outcomes, adverse-event monitoring, patient-reported symptoms, and durability of sinus patency rather than device placement alone.

Artificial Intelligence Strengthens Selection, Planning, and Follow-Up

Artificial intelligence can support this field by helping clinicians analyze imaging, classify inflammatory or anatomical patterns, identify patients who may benefit from localized therapy, and standardize postoperative assessment. Machine-learning tools may also assist with image-based measurement of sinus openings and detection of recurrent disease. However, clinical accountability remains with qualified professionals, and AI systems require representative validation, transparent performance evaluation, privacy safeguards, and integration with clinical workflows. AI should complement-not replace-endoscopic examination, imaging, and multidisciplinary judgment.

Regional Insights: Adoption Depends on Care Pathways and Regulation

North America is characterized by established endoscopic sinus surgery pathways, specialist care, and strong attention to clinical evidence and reimbursement. Europe places substantial emphasis on regulatory conformity, health-system value, and harmonized clinical practice, while variation among countries can affect access. Asia-Pacific combines advanced specialist centers with uneven healthcare infrastructure and differing regulatory environments, creating opportunities for locally appropriate training and evidence. Latin America is influenced by reimbursement constraints, import requirements, and concentration of specialist services in major urban areas. The Middle East shows demand centered on advanced hospitals and referral networks, while Africa’s adoption is more dependent on tertiary-care capacity, affordability, supply continuity, and specialist availability.

Group Insights: Economic Blocs Shape Access and Evidence Requirements

ASEAN markets are diverse in regulatory maturity, healthcare financing, and specialist availability, making distribution and training strategies particularly important. BRICS countries span large and varied healthcare systems, with opportunities shaped by domestic manufacturing, procurement policies, and unequal access to advanced sinus care. The European Union benefits from regulatory coordination while retaining national differences in reimbursement and clinical adoption. G7 systems generally have mature specialist services and higher expectations for evidence, safety monitoring, and health-economic justification. GCC countries often rely on well-equipped referral hospitals and centralized procurement, whereas NATO members exhibit diverse health systems but frequently share interests in surgical capability, resilience of medical supply chains, and standardized professional training.

Country Insights: Different Health Systems Require Local Execution

Australia and Canada emphasize specialist-led care, evidence-based adoption, and geographically sensitive access. Brazil and Mexico face substantial differences between urban referral centers and broader public or private networks. China and India combine expanding procedural capacity with large regional variations in regulation, affordability, and specialist training. Japan, South Korea, Singapore, and other advanced Asian systems generally have strong hospital capabilities, though reimbursement and approval pathways remain decisive. France, Germany, Italy, Spain, and the United Kingdom evaluate adoption through national or regional clinical, regulatory, and procurement structures. Russia’s access is influenced by domestic supply, institutional capacity, and regulatory conditions. Across the United States, adoption is shaped by specialist practice patterns, payer policies, evidence requirements, and facility-level purchasing decisions.

Actions for Leaders: Prove Value, Simplify Use, and Build Access

Industry leaders should prioritize high-quality clinical studies that compare biodegradable stent systems with relevant standard care and report patient-centered outcomes, complications, reintervention, device handling, and resorption behavior. Product development should focus on predictable degradation, controlled drug delivery, atraumatic placement, clear labeling, and compatibility with routine surgical instruments. Commercial and clinical teams should build structured training, postoperative monitoring protocols, and evidence packages tailored to regulatory and reimbursement requirements in each geography. Partnerships with specialist centers can support real-world evaluation, while supply-chain planning and transparent risk communication are essential for sustainable adoption.

Research Methodology: Evidence-Based Executive Assessment

This executive summary applies a structured qualitative review of the biodegradable sinus drug stent system category. The assessment considers device function, clinical workflow, safety and evidence expectations, regulatory and reimbursement influences, healthcare-system maturity, specialist capacity, and access conditions across the required regions, groups, and countries. Artificial intelligence is evaluated as an enabling technology rather than as a substitute for clinical judgment. No market estimates, market shares, forecasts, or company-specific claims are used; conclusions are framed as evidence-oriented strategic considerations requiring validation against current clinical literature, regulatory materials, and local healthcare policies.

Conclusion: Clinical Evidence and Local Readiness Will Determine Progress

Biodegradable sinus drug stent systems sit at the intersection of minimally invasive surgery, localized drug delivery, absorbable biomaterials, and postoperative disease management. Their successful integration will depend less on novelty alone than on reproducible clinical benefit, safe degradation, clinician confidence, appropriate patient selection, and practical access. Organizations that combine rigorous evidence generation with region-specific regulatory planning, training, monitoring, and affordability strategies will be better positioned to support responsible use across diverse healthcare environments.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Biodegradable Sinus Drug Stent System Market, by Indication
7.1. Introduction
7.2. Chronic Rhinosinusitis With Nasal Polyps
7.3. Chronic Rhinosinusitis Without Nasal Polyps
7.4. Postoperative Management
8. Biodegradable Sinus Drug Stent System Market, by Material Type
8.1. Introduction
8.2. Polydioxanone
8.3. Polyglycolic Acid
8.4. Polylactic Acid
9. Biodegradable Sinus Drug Stent System Market, by Drug Type
9.1. Introduction
9.2. Antibiotics
9.2.1. Azithromycin
9.2.2. Ciprofloxacin
9.3. Antifungals
9.3.1. Amphotericin B
9.3.2. Fluconazole
9.4. Corticosteroids
9.4.1. Budesonide
9.4.2. Fluticasone
9.4.3. Mometasone Furoate
10. Biodegradable Sinus Drug Stent System Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Clinics
10.4. Hospitals
11. Biodegradable Sinus Drug Stent System Market, by Patient Age Group
11.1. Introduction
11.2. Adult
11.3. Geriatric
11.4. Pediatric
12. Biodegradable Sinus Drug Stent System Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Biodegradable Sinus Drug Stent System Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Biodegradable Sinus Drug Stent System Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Acclarent, Inc.
16.2. Boston  Scientific  Corporation
16.3. ENTellus  Medical, Inc.
16.4. Hemostasis  LLC
16.5. Intersect ENT, Inc.
16.6. Johnson & Johnson Services, Inc.
16.7. KARL STORZ SE & Co.  KG
16.8. Medica  Holdings, LLC
16.9. Medtronic  plc
16.10. Meril  Life  Sciences  Pvt.  Ltd.
16.11. Olympus  Corporation
16.12. Poly-Med,  Inc.
16.13. Shanghai INT Medical Instruments Co., Ltd.
16.14. SinuSys  Corporation
16.15. Smith & Nephew  plc
16.16. Spiggle & Theis  Medizintechnik  GmbH
16.17. Stening  Sinus  Technologies,  LLC
16.18. Stryker  Corporation
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Biodegradable Sinus Drug Stent System Market, Years Considered for the Study
FIGURE 2. Global Biodegradable Sinus Drug Stent System Market, Research Design
FIGURE 3. Global Biodegradable Sinus Drug Stent System Market, Research Framework
FIGURE 4. Global Biodegradable Sinus Drug Stent System Market, Data Triangulation
FIGURE 5. Global Biodegradable Sinus Drug Stent System Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Biodegradable Sinus Drug Stent System Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 7. Global Biodegradable Sinus Drug Stent System Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2025 vs 2032 (%)
FIGURE 9. Global Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2025 vs 2032 (%)
FIGURE 11. Global Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Biodegradable Sinus Drug Stent System Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Biodegradable Sinus Drug Stent System Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2025 vs 2032 (%)
FIGURE 15. Global Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Biodegradable Sinus Drug Stent System Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Biodegradable Sinus Drug Stent System Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Biodegradable Sinus Drug Stent System Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Biodegradable Sinus Drug Stent System Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Biodegradable Sinus Drug Stent System Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Biodegradable Sinus Drug Stent System Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Biodegradable Sinus Drug Stent System Market Segmentation & Coverage
TABLE 2. Global Biodegradable Sinus Drug Stent System Market Size, 2017-2032 (USD Million)
TABLE 3. Global Biodegradable Sinus Drug Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 4. Global Chronic Rhinosinusitis With Nasal Polyps Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Chronic Rhinosinusitis With Nasal Polyps Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Chronic Rhinosinusitis With Nasal Polyps Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Chronic Rhinosinusitis Without Nasal Polyps Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Chronic Rhinosinusitis Without Nasal Polyps Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Chronic Rhinosinusitis Without Nasal Polyps Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Postoperative Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Postoperative Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Postoperative Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 14. Global Polydioxanone Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Polydioxanone Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Polydioxanone Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Polyglycolic Acid Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Polyglycolic Acid Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Polyglycolic Acid Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Polylactic Acid Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Polylactic Acid Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Polylactic Acid Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 24. Global Antibiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Antibiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Antibiotics Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Azithromycin Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Azithromycin Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Azithromycin Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Ciprofloxacin Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Ciprofloxacin Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Ciprofloxacin Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Antifungals Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Antifungals Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Antifungals Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Amphotericin B Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Amphotericin B Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Amphotericin B Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Fluconazole Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Fluconazole Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Fluconazole Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Corticosteroids Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Corticosteroids Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Corticosteroids Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Budesonide Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Budesonide Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Budesonide Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Fluticasone Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Fluticasone Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Fluticasone Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Mometasone Furoate Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Mometasone Furoate Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Mometasone Furoate Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Biodegradable Sinus Drug Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 55. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 65. Global Adult Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Adult Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Adult Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Geriatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Geriatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Geriatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Biodegradable Sinus Drug Stent System Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Biodegradable Sinus Drug Stent System Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Biodegradable Sinus Drug Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Biodegradable Sinus Drug Stent System Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Biodegradable Sinus Drug Stent System Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Biodegradable Sinus Drug Stent System Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Biodegradable Sinus Drug Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 84. North America Biodegradable Sinus Drug Stent System Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. North America Biodegradable Sinus Drug Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 86. North America Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 87. North America Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 88. North America Biodegradable Sinus Drug Stent System Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 89. North America Biodegradable Sinus Drug Stent System Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 90. North America Biodegradable Sinus Drug Stent System Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 91. North America Biodegradable Sinus Drug Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 92. North America Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 93. Latin America Biodegradable Sinus Drug Stent System Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Latin America Biodegradable Sinus Drug Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 95. Latin America Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 96. Latin America Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 97. Latin America Biodegradable Sinus Drug Stent System Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 98. Latin America Biodegradable Sinus Drug Stent System Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 99. Latin America Biodegradable Sinus Drug Stent System Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 100. Latin America Biodegradable Sinus Drug Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 101. Latin America Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 102. Europe Biodegradable Sinus Drug Stent System Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Europe Biodegradable Sinus Drug Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 104. Europe Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 105. Europe Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 106. Europe Biodegradable Sinus Drug Stent System Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 107. Europe Biodegradable Sinus Drug Stent System Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 108. Europe Biodegradable Sinus Drug Stent System Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 109. Europe Biodegradable Sinus Drug Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 110. Europe Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 111. Middle East Biodegradable Sinus Drug Stent System Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Middle East Biodegradable Sinus Drug Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 113. Middle East Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 114. Middle East Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 115. Middle East Biodegradable Sinus Drug Stent System Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 116. Middle East Biodegradable Sinus Drug Stent System Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 117. Middle East Biodegradable Sinus Drug Stent System Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 118. Middle East Biodegradable Sinus Drug Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 119. Middle East Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 120. Africa Biodegradable Sinus Drug Stent System Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Africa Biodegradable Sinus Drug Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 122. Africa Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 123. Africa Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 124. Africa Biodegradable Sinus Drug Stent System Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 125. Africa Biodegradable Sinus Drug Stent System Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 126. Africa Biodegradable Sinus Drug Stent System Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 127. Africa Biodegradable Sinus Drug Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. Africa Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 129. Global Biodegradable Sinus Drug Stent System Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. ASEAN Biodegradable Sinus Drug Stent System Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. ASEAN Biodegradable Sinus Drug Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 132. ASEAN Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 133. ASEAN Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 134. ASEAN Biodegradable Sinus Drug Stent System Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 135. ASEAN Biodegradable Sinus Drug Stent System Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 136. ASEAN Biodegradable Sinus Drug Stent System Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 137. ASEAN Biodegradable Sinus Drug Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. ASEAN Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 139. GCC Biodegradable Sinus Drug Stent System Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. GCC Biodegradable Sinus Drug Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 141. GCC Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 142. GCC Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 143. GCC Biodegradable Sinus Drug Stent System Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 144. GCC Biodegradable Sinus Drug Stent System Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 145. GCC Biodegradable Sinus Drug Stent System Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 146. GCC Biodegradable Sinus Drug Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. GCC Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 148. European Union Biodegradable Sinus Drug Stent System Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. European Union Biodegradable Sinus Drug Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 150. European Union Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 151. European Union Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 152. European Union Biodegradable Sinus Drug Stent System Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 153. European Union Biodegradable Sinus Drug Stent System Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 154. European Union Biodegradable Sinus Drug Stent System Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 155. European Union Biodegradable Sinus Drug Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 156. European Union Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 157. BRICS Biodegradable Sinus Drug Stent System Market Size, by Group, 2017-2032 (USD Million)
TABLE 158. BRICS Biodegradable Sinus Drug Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 159. BRICS Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 160. BRICS Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 161. BRICS Biodegradable Sinus Drug Stent System Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 162. BRICS Biodegradable Sinus Drug Stent System Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 163. BRICS Biodegradable Sinus Drug Stent System Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 164. BRICS Biodegradable Sinus Drug Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. BRICS Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 166. G7 Biodegradable Sinus Drug Stent System Market Size, by Group, 2017-2032 (USD Million)
TABLE 167. G7 Biodegradable Sinus Drug Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 168. G7 Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 169. G7 Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 170. G7 Biodegradable Sinus Drug Stent System Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 171. G7 Biodegradable Sinus Drug Stent System Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 172. G7 Biodegradable Sinus Drug Stent System Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 173. G7 Biodegradable Sinus Drug Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 174. G7 Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 175. NATO Biodegradable Sinus Drug Stent System Market Size, by Group, 2017-2032 (USD Million)
TABLE 176. NATO Biodegradable Sinus Drug Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 177. NATO Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 178. NATO Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 179. NATO Biodegradable Sinus Drug Stent System Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 180. NATO Biodegradable Sinus Drug Stent System Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 181. NATO Biodegradable Sinus Drug Stent System Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 182. NATO Biodegradable Sinus Drug Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 183. NATO Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 184. Global Biodegradable Sinus Drug Stent System Market Size, by Country, 2017-2032 (USD Million)
TABLE 185. United States Biodegradable Sinus Drug Stent System Market Size, 2017-2032 (USD Million)
TABLE 186. United States Biodegradable Sinus Drug Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 187. United States Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 188. United States Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 189. United States Biodegradable Sinus Drug Stent System Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 190. United States Biodegradable Sinus Drug Stent System Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 191. United States Biodegradable Sinus Drug Stent System Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 192. United States Biodegradable Sinus Drug Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. United States Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 194. Canada Biodegradable Sinus Drug Stent System Market Size, 2017-2032 (USD Million)
TABLE 195. Canada Biodegradable Sinus Drug Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 196. Canada Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 197. Canada Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 198. Canada Biodegradable Sinus Drug Stent System Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 199. Canada Biodegradable Sinus Drug Stent System Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 200. Canada Biodegradable Sinus Drug Stent System Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 201. Canada Biodegradable Sinus Drug Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 202. Canada Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 203. Mexico Biodegradable Sinus Drug Stent System Market Size, 2017-2032 (USD Million)
TABLE 204. Mexico Biodegradable Sinus Drug Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 205. Mexico Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 206. Mexico Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 207. Mexico Biodegradable Sinus Drug Stent System Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 208. Mexico Biodegradable Sinus Drug Stent System Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 209. Mexico Biodegradable Sinus Drug Stent System Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 210. Mexico Biodegradable Sinus Drug Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. Mexico Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 212. Brazil Biodegradable Sinus Drug Stent System Market Size, 2017-2032 (USD Million)
TABLE 213. Brazil Biodegradable Sinus Drug Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 214. Brazil Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 215. Brazil Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 216. Brazil Biodegradable Sinus Drug Stent System Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 217. Brazil Biodegradable Sinus Drug Stent System Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 218. Brazil Biodegradable Sinus Drug Stent System Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 219. Brazil Biodegradable Sinus Drug Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 220. Brazil Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 221. United Kingdom Biodegradable Sinus Drug Stent System Market Size, 2017-2032 (USD Million)
TABLE 222. United Kingdom Biodegradable Sinus Drug Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 223. United Kingdom Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 224. United Kingdom Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 225. United Kingdom Biodegradable Sinus Drug Stent System Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 226. United Kingdom Biodegradable Sinus Drug Stent System Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 227. United Kingdom Biodegradable Sinus Drug Stent System Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 228. United Kingdom Biodegradable Sinus Drug Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 229. United Kingdom Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 230. Germany Biodegradable Sinus Drug Stent System Market Size, 2017-2032 (USD Million)
TABLE 231. Germany Biodegradable Sinus Drug Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 232. Germany Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 233. Germany Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 234. Germany Biodegradable Sinus Drug Stent System Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 235. Germany Biodegradable Sinus Drug Stent System Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 236. Germany Biodegradable Sinus Drug Stent System Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 237. Germany Biodegradable Sinus Drug Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 238. Germany Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 239. France Biodegradable Sinus Drug Stent System Market Size, 2017-2032 (USD Million)
TABLE 240. France Biodegradable Sinus Drug Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 241. France Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 242. France Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 243. France Biodegradable Sinus Drug Stent System Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 244. France Biodegradable Sinus Drug Stent System Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 245. France Biodegradable Sinus Drug Stent System Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 246. France Biodegradable Sinus Drug Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 247. France Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 248. Russia Biodegradable Sinus Drug Stent System Market Size, 2017-2032 (USD Million)
TABLE 249. Russia Biodegradable Sinus Drug Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 250. Russia Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 251. Russia Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 252. Russia Biodegradable Sinus Drug Stent System Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 253. Russia Biodegradable Sinus Drug Stent System Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 254. Russia Biodegradable Sinus Drug Stent System Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 255. Russia Biodegradable Sinus Drug Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 256. Russia Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 257. Italy Biodegradable Sinus Drug Stent System Market Size, 2017-2032 (USD Million)
TABLE 258. Italy Biodegradable Sinus Drug Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 259. Italy Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 260. Italy Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 261. Italy Biodegradable Sinus Drug Stent System Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 262. Italy Biodegradable Sinus Drug Stent System Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 263. Italy Biodegradable Sinus Drug Stent System Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 264. Italy Biodegradable Sinus Drug Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 265. Italy Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 266. Spain Biodegradable Sinus Drug Stent System Market Size, 2017-2032 (USD Million)
TABLE 267. Spain Biodegradable Sinus Drug Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 268. Spain Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 269. Spain Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 270. Spain Biodegradable Sinus Drug Stent System Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 271. Spain Biodegradable Sinus Drug Stent System Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 272. Spain Biodegradable Sinus Drug Stent System Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 273. Spain Biodegradable Sinus Drug Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 274. Spain Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 275. China Biodegradable Sinus Drug Stent System Market Size, 2017-2032 (USD Million)
TABLE 276. China Biodegradable Sinus Drug Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 277. China Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 278. China Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 279. China Biodegradable Sinus Drug Stent System Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 280. China Biodegradable Sinus Drug Stent System Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 281. China Biodegradable Sinus Drug Stent System Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 282. China Biodegradable Sinus Drug Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 283. China Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 284. India Biodegradable Sinus Drug Stent System Market Size, 2017-2032 (USD Million)
TABLE 285. India Biodegradable Sinus Drug Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 286. India Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 287. India Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 288. India Biodegradable Sinus Drug Stent System Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 289. India Biodegradable Sinus Drug Stent System Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 290. India Biodegradable Sinus Drug Stent System Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 291. India Biodegradable Sinus Drug Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 292. India Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 293. Japan Biodegradable Sinus Drug Stent System Market Size, 2017-2032 (USD Million)
TABLE 294. Japan Biodegradable Sinus Drug Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 295. Japan Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 296. Japan Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 297. Japan Biodegradable Sinus Drug Stent System Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 298. Japan Biodegradable Sinus Drug Stent System Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 299. Japan Biodegradable Sinus Drug Stent System Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 300. Japan Biodegradable Sinus Drug Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 301. Japan Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 302. Australia Biodegradable Sinus Drug Stent System Market Size, 2017-2032 (USD Million)
TABLE 303. Australia Biodegradable Sinus Drug Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 304. Australia Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 305. Australia Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 306. Australia Biodegradable Sinus Drug Stent System Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 307. Australia Biodegradable Sinus Drug Stent System Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 308. Australia Biodegradable Sinus Drug Stent System Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 309. Australia Biodegradable Sinus Drug Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 310. Australia Biodegradable Sinus Drug Stent System Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 311. South Korea Biodegradable Sinus Drug Stent System Market Size, 2017-2032 (USD Million)
TABLE 312. South Korea Biodegradable Sinus Drug Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 313. South Korea Biodegradable Sinus Drug Stent System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 314. South Korea Biodegradable Sinus Drug Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 315. South Korea Biodegradable Sinus Drug Stent System Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 316. South Korea Biodegradable Sinus Drug Stent System Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 317. South

Companies Mentioned

  • Acclarent, Inc.
  • Boston  Scientific  Corporation
  • ENTellus  Medical, Inc.
  • Hemostasis  LLC
  • Intersect ENT, Inc.
  • Johnson & Johnson Services, Inc.
  • KARL STORZ SE & Co.  KG
  • Medica  Holdings, LLC
  • Medtronic  plc
  • Meril  Life  Sciences  Pvt.  Ltd.
  • Olympus  Corporation
  • Poly‑Med,  Inc.
  • Shanghai INT Medical Instruments Co., Ltd.
  • SinuSys  Corporation
  • Smith & Nephew  plc
  • Spiggle & Theis  Medizintechnik  GmbH
  • Stening  Sinus  Technologies,  LLC
  • Stryker  Corporation

Related Topics

Related Reports

Implantable Coronary Drug Eluting Stent Market - Global Forecast 2026-2032 - Product Image

Implantable Coronary Drug Eluting Stent Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Biodegradable Coronary Stents Market - Global Forecast 2026-2032 - Product Image

Biodegradable Coronary Stents Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Non-Vascular Stents - Global Strategic Business Report - Product Image

Non-Vascular Stents - Global Strategic Business Report

  • Report
  • 242 Pages
  • Global
From
Ureteral Stents Market Size, Share, Trends and Forecast by Product Type, Material, Application, End Use, and Region, 2026-2034 - Product Image

Ureteral Stents Market Size, Share, Trends and Forecast by Product Type, Material, Application, End Use, and Region, 2026-2034

  • Report
  • 144 Pages
  • Global
From
Biodegradable Stents - Global Strategic Business Report - Product Image

Biodegradable Stents - Global Strategic Business Report

  • Report
  • 274 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.